drugset / Trial / NCT03680378

Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)

NCT03680378

Phase 1 Completed 19 enrolled Allecra
NaSingle-groupOpen-labelOther

Summary

The primary objective of this study is to measure and compare the concentration of AAI101 and cefepime in bronchial epithelial lining fluid (ELF) and plasma following administration of cefepime/AAI101 combination in healthy subjects.

Timeline

Start
2017-07-01
Primary completion
2019-04-30
Completion
2019-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefepime Small molecule 2 g Intravenous
Subject enmetazobactam Small molecule 1 g Intravenous

Indications

No indication recorded.